Pediatric Trauma Centers RE-AIM at Gun Safety
Launched by JOHNS HOPKINS UNIVERSITY · Nov 8, 2023
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- For parents/guardians of pediatric trauma patients:
- Inclusion Criteria:
- • live with an admitted pediatric trauma patient at a participating trauma center
- • be fluent in English or Spanish
- Exclusion Criteria:
- • - family members who do not live with the admitted pediatric trauma patient
- For youth trauma patients:
- Inclusion Criteria:
- • Must be between the ages of 11-17 years
- • admitted to a participating trauma inpatient service for an injury
- • fluent in English or Spanish
- • able to provide written assent and parent able to provide written consent
- Exclusion Criteria:
- • Youth who are prisoners or in police custody
- • Youth who are admitted due to suicide attempt
- • Youth with acute conditions that would preclude provision of informed consent (i.e., acute psychosis, altered mental status, cognitive impairment)
About Johns Hopkins University
Johns Hopkins University, a prestigious research institution located in Baltimore, Maryland, is renowned for its commitment to advancing medical science and public health through innovative clinical trials. With a rich history of groundbreaking research and a multidisciplinary approach, the university's clinical trial initiatives focus on translating scientific discoveries into effective treatments and interventions. Leveraging state-of-the-art facilities and a collaborative network of experts, Johns Hopkins University conducts rigorous clinical studies that aim to improve patient outcomes and address critical health challenges. Its dedication to ethical standards and participant safety underscores its role as a leader in clinical research.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Katherine Hoops, MD, PhD
Principal Investigator
Johns Hopkins School of Medicine
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported